Sebastian Schöfer
Director/Board Member at Ferroelectric Memory GmbH
Network origin in Sebastian Schöfer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands.
52
| Operating Division | Investment Managers | 52 |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany.
29
| Private Company | Investment Managers | 29 |
Ferroelectric Memory GmbH
Ferroelectric Memory GmbH SemiconductorsElectronic Technology Ferroelectric Memory GmbH (FMC) is a German company that has developed advanced ferroelectric hafnium oxide memory technology for non-volatile memory in future electronics and computing innovation. The company is based in Dresden, Germany. FMC's ferroelectric field-effect transistor (FEFET) and capacitor (FECAP) technology is fast, low-power, scalable, and has high endurance with decades of data retention, suitable for a broad range of AI, IoT, edge, data center, and embedded applications. The company was founded in 2016 by Marko Noack, Wolfram Drescher, Stefan Mueller, Menno Mennenga, and is currently working with major semiconductor companies for its embedded and stand-alone memory solution. The CEO is Ali Pourkeramati.
10
| Holding Company | Semiconductors | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sebastian Schöfer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Virage Logic Corp.
Virage Logic Corp. SemiconductorsElectronic Technology Virage Logic Corp. is a technology and market provider in advanced embedded memory intellectual property (IP) for the design of complex integrated circuits. It work on semiconductor IP platforms comprising embedded memory, standard cells, and I/Os primarily for the consumer, communications and networking, handheld and portable, and computer and graphics markets. The company's quality efforts are validated in its Silicon Characterization lab which ensures quality, reliable IP across a range of foundries and process technologies. The company was founded on 1996 and is headquartered in Fremont, CA. | Semiconductors | Chief Executive Officer | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
Amadeus Capital Partners Ltd.
Amadeus Capital Partners Ltd. Investment ManagersFinance Amadeus Capital Partners Ltd is an independent venture capital firm is founded by Anne Glover and Hermann Hauser in 1997. The firm is headquartered in London, UK. | Investment Managers | Private Equity Investor | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst | |
Santa Clara University | College/University | Graduate Degree Graduate Degree | |
Technische Universität München | College/University | Masters Business Admin Graduate Degree | |
University of St. Andrews | College/University | Undergraduate Degree Undergraduate Degree | |
University College London | College/University | Undergraduate Degree Doctorate Degree | |
RWTH Aachen University | College/University | Graduate Degree Graduate Degree | |
University of Innsbruck | College/University | Graduate Degree | |
University of Zurich | College/University | Doctorate Degree | |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Sales & Marketing | |
Nauta Capital VC Partners SGEIC SA
Nauta Capital VC Partners SGEIC SA Investment ManagersFinance Nauta Capital VC Partners SGEIC SA (Nauta Capital) is an independent venture capital firm founded in 2004 by Marcel Rafart Vicent, Javier Rubió Planellas and Daniel Sánchez Jiménez. The firm is headquartered in Barcelona, Spain with additional office in London. | Investment Managers | Private Equity Investor | |
eCapital entrepreneurial Partners AG
eCapital entrepreneurial Partners AG Investment ManagersFinance eCAPITAL entrepreneurial Partners AG (eCAPITAL) is a venture capital firm founded in 1999. The firm is headquartered in Münster, Germany. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | Investment Managers | Private Equity Analyst | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
Hanse Ventures BSJ GmbH
Hanse Ventures BSJ GmbH Investment ManagersFinance Hanse Ventures BSJ GmbH (Hanse Ventures) is an independent ventures capital firm headquartered in Hamburg, Germany. It was founded in 2010 by Jochen Maaß, Dr. Bernd Kundrun and Rolf Schmitz-Holtz. | Investment Managers | Private Equity Investor | |
Implandata Ophthalmic Products GmbH
Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Unternehmertum Venture Capital Partners GmbH
Unternehmertum Venture Capital Partners GmbH Investment ManagersFinance Unternehmertum Venture Capital Partners GmbH (UVC Partners) is a venture capital subsidiary of UnternehmerTUM GmbH, founded in 2011. The firm is headquartered in Munich, Germany, with an additional office in Berlin. | Investment Managers | Private Equity Investor | |
Capnamic Ventures Management GmbH
Capnamic Ventures Management GmbH Investment ManagersFinance Capnamic Ventures Management GmbH (Capnamic Ventures) is an independent venture capital firm founded by Christian Siegele and Jörg Binnenbrücker in 2010. It is headquartered in Cologne, Germany, with another German office in Berlin. | Investment Managers | Private Equity Investor Private Equity Investor | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Indi Molecular, Inc.
Indi Molecular, Inc. BiotechnologyHealth Technology Indi Molecular, Inc. is a life sciences company that develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. It offers products used by physicians and patients to manage complex and serious diseases like cancer, diabetes, and Alzheimer's. The company was founded by Michael Phelps, Albert A. Luderer, Leroy E. Hood, and Jim Heath in 2013 and is headquartered in Culver City, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Lundbeckfonden Emerge
Lundbeckfonden Emerge Investment ManagersFinance Lundbeckfonden Emerge (Emerge) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2012 and is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor | |
coramaze technologies GmbH
coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
SynAffix BV
SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Calypso Biotech SA
Calypso Biotech SA Pharmaceuticals: MajorHealth Technology Calypso Biotech SA operates as a innovative biopharmaceutical company for gastrointestinal immunological disorders. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Plan-les-Ouates, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medisafe Project Ltd.
Medisafe Project Ltd. Hospital/Nursing ManagementHealth Services Medisafe Project Ltd. develops a cloud-synced mobile medication management system. Its platform helps the user manage and take medication on time. The company was founded by Omri Shor and Rotem Shor in 2012 and is headquartered in Matam, Israel. | Hospital/Nursing Management | Director/Board Member | |
MAIRDUMONT VENTURES GmbH
MAIRDUMONT VENTURES GmbH Investment ManagersFinance MAIRDUMONT VENTURES GmbH (MAIRDUMONT VENTURES) is the venture capital arm of MAIRDUMONT GmbH & Co. KG. The firm was established in 2015. It is headquartered in Ostfildern, Germany, with another German office located in Munich. | Investment Managers | Private Equity Investor | |
CAPITAL ONE AG | Financial Conglomerates | Chief Executive Officer | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Biotechnology | Chairman Director/Board Member | |
52Masterworks GmbH
52Masterworks GmbH Packaged SoftwareTechnology Services 52Masterworks GmbH operates an online platform that provides website designing services. The company was founded by Tobias Ledermann, Björn Jopen, Christian Utz, Robert Herrmann, and Andreas Unseld in 2013 and is headquartered in München, Germany. | Packaged Software | Founder | |
Biolinq, Inc.
Biolinq, Inc. Electronic Production EquipmentElectronic Technology Biolinq, Inc. develops skin-applied electronic sensors that analyze body fluids to provide health information. The company was founded by Jared Tangney and Josh Windmiller in 2012 and is headquartered in San Diego, CA. | Electronic Production Equipment | Director/Board Member | |
Sonde Health, Inc.
Sonde Health, Inc. Packaged SoftwareTechnology Services Sonde Health, Inc. develops voice-based technology platform to monitor and diagnose psychological and physical medical conditions. The company was founded by Michael C. Chen and James Harper in 2015 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
iOnctura SA
iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member | |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Loqus23 Therapeutics Ltd.
Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Biotechnology | Director/Board Member | |
Transine Therapeutics Ltd.
Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Consultant / Advisor | |
ENGENE HOLDINGS INC. | Biotechnology | Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
Germany | 13 |
United States | 10 |
Switzerland | 9 |
Netherlands | 7 |
United Kingdom | 7 |
Sectoral
Finance | 21 |
Health Technology | 15 |
Consumer Services | 9 |
Electronic Technology | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 171 |
Private Equity Investor | 86 |
Private Equity Analyst | 56 |
Corporate Officer/Principal | 34 |
Chief Executive Officer | 24 |
Most connected contacts
Insiders | |
---|---|
Joey Mason | 31 |
Roel Bulthuis | 29 |
Daniel Artusi | 24 |
Hakan Goker | 18 |
Matthias Dill | 16 |
Jasper Bos | 15 |
Dave Rosenberg | 15 |
Paul-Josef Patt | 14 |
Adam A. Kablanian | 11 |
Yoni Blau | 11 |
Hans Rohrer | 10 |
Cyril Vancura | 9 |
Yann Fiebig | 8 |
Alberto Libanori | 8 |
Ali Pourkeramati | 8 |
- Stock Market
- Insiders
- Sebastian Schöfer
- Company connections